ArticleParasites & vectors2025
Early host-parasite interaction models reveal a key role for fibrinolysis in Fasciola hepatica intestinal migration.
Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Fibrinolysis-unrelated functions of the plasminogen/plasmin system: A gateway to successful parasitism?Current research in parasitology & vector-borne diseases · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundFasciola hepatica is the most common etiologic agent of fasciolosis, a parasitic disease that affects millions of ruminants worldwide and a zoonotic human infection of public health concern. Upon ingestion of infective metacercariae, F. hepatica newly excysted juveniles (FhNEJ) emerge in the duodenum and cross the intestinal wall to initiate a migration route that culminates with their establishment within the hepatic bile ducts. The ability of FhNEJ to exploit the broad-spectrum activities of host plasmin, the central protease of the fibrinolytic system, has been proposed as a strategy employed by these parasites to migrate across the intestinal wall while minimising energy expenditure.
methodsMouse intestinal epithelial cells (mPSIEC) were stimulated with FhNEJ and plasminogen (PLG), the zymogen of plasmin, to understand whether FhNEJ-stimulated plasmin generation modulates processes relevant to parasite migration through the intestinal wall, including extracellular matrix (ECM) degradation and the secretion of ECM-degrading enzymes. Plasmin-mediated cellular responses were further examined by proteomic analysis of mPSIEC whole-cell lysates. In parallel, the contribution of the fibrinolytic system in FhNEJ migration was studied in vivo by infecting mice with F. hepatica metacercariae following pharmacological inhibition of fibrinolysis.
resultsCo-stimulation of mPSIEC with FhNEJ and PLG led to increased plasmin generation in the intestinal pericellular space, which was associated with enhanced collagen degradation and secretion of the urokinase-type plasminogen activator. In addition, using independent cell culture replicates and a stringent statistical pipeline, we identified a robust set of differentially expressed proteins in mPSIEC following stimulation with FhNEJ and PLG. These proteins were involved in cell adhesion, migration, ECM remodelling, immune evasion and fibrinolysis. Despite inter-experimental variability, FhNEJ migration in mice was reduced upon pharmacological inhibition of fibrinolysis, supporting the contribution of host fibrinolysis to parasite invasion in vivo.
conclusionsAltogether, this work provides unprecedented insights into the role of the host fibrinolytic system to FhNEJ migration across mammalian host tissues, thereby advancing our understanding of host-parasite relationships during early stage fasciolosis and highlighting interesting directions for future research in this area.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.